Passing the Alternatives to PAIN Act would be an excellent way for Trump to uphold his promise to “Make America Healthy Again ...

The opioid crisis has touched nearly every demographic in our society. One area that doesn’t get enough attention is the toll ...

Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with its substantial $114.5 billion market capitalization, continues to dominate the cystic fibrosis (CF) treatment market while advancing a ...

Pat George, chairman of the Kansas Fights Addiction Act Grant Review Board, gives an update to the Senate Ways and Means ...

In the face of a relentless assault on our nation's well-being, the National Police Association (NPA) endorsed the Stopping Overdoses of Fentanyl Analogues (SOFA) Act. This legislation, championed by ...

Donald Trump is testing the limits of his power yet again—this time with the firing of multiple people on the National Labor ...

Kashiv Biosciences, LLC, a global leader in biopharmaceutical innovation, today announced that their abatacept biosimilar candidate, KSHB002, has successfully met the primary endpoints in its Phase 1 ...

Around two-thirds of people relapse within 30 days after being discharged from residential treatment. An app could help them ...

Despite the removal of the X-waiver requirement, which once restricted clinicians from prescribing buprenorphine for opioid ...